• ქართული
  • English
  • Novartis posts first-quarter sales, profit beat as COVID-19 spurs prescriptions

    Swiss drugmaker Novartis reported rising first-quarter sales and profit that beat analyst expectations and confirmed its 2020 targets as the coronavirus pandemic prompted patients to stock up on their prescriptions in advance.

    Market Quotes by TradingView